Sentence examples for utility in the screening from inspiring English sources

It has therefore been suggested that PB gene expression profiling has potential utility in the screening for diseases and environmental exposures.

Whereas a wide range of sensitivity and specificity values of AAA-IgA have been reported, questioning its utility in the screening for CD [ 19], our data suggest that the best usage of AAA-IgA measurement in the diagnosis of CD is not as an isolated test, but in association with anti-TG2 values comprised between 4 and 10 times ULN.

79 The factors suggesting that a lung cancer risk stratification test may have clinical utility in the general screening of smokers are summarized in Table 3.

To date, few data have been published regarding the utility of the screening urinalysis in this role.

Taken together, the current data indicate that the Berlin questionnaire might have limited utility in OSA screening due to the inclusion of obesity as one of the classification criteria.

First, from the perspectives of screening providers through an evaluation of effectiveness in mortality reduction, we can fully understand whether the screening strategy is feasible and what the utility of the screening program is in association with the incurred budget.

The SCIT may have utility in cognitive screening of elderly populations, since it is well tolerated by the elderly, and performance on the SCIT has previously been shown to be sensitive to decrements in performance on the MMSE.

In research settings there is high utility in the ability to rapidly screen profiles to identify interesting density subfractions for further compositional characterization [ 18, 19].

These results suggest that testing for germline CHEK2 mutations improves the ability to predict the presence of prostate cancer in screened men, however, the clinical utility of incorporating DNA variants in the screening process is marginal.

Our aim is to evaluate the cost-utility of the screening program in the total invitation- to- screen PREDICA cohort, including self-selected participants as well as individuals who were invited to the screening but decided not to participate.

Biomarker testing in such samples is likely to improve validity and confidence in identifying markers with screening utility in the absence of clinical stage confounders (Pepe et al, 2008; Buchen, 2011).